Literature DB >> 30580419

Cell-Free DNA: Applications in Different Diseases.

Rossella Ranucci1.   

Abstract

Since its discovery in human blood plasma about 70 years ago, circulating cell-free DNA (cfDNA) has become an attractive subject of research as noninvasive disease biomarker. The interest in clinical applications has gained an exponential increase, making it a popular and potential target in a wide range of research areas.cfDNA can be found in different body fluids, both in healthy and not healthy subjects. The recent and rapid development of new molecular techniques is promoting the study and the identification of cfDNA, holding the key to minimally invasive diagnostics, improving disease monitoring, clinical decision, and patients' outcome.cfDNA has already given a huge impact on prenatal medicine, and it could become, in the next future, the standard of care also in other fields, from oncology to transplant medicine and cardiovascular diseases.

Entities:  

Keywords:  Cell-free DNA; Cell-free fetal DNA; Circulating tumor DNA; Clinical application; Liquid biopsy

Mesh:

Substances:

Year:  2019        PMID: 30580419     DOI: 10.1007/978-1-4939-8973-7_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  Urinary cell-free extrachromosomal circular DNAs: A possible biomarker for chronic kidney disease.

Authors:  Selami Demirci
Journal:  Clin Transl Med       Date:  2022-06

2.  The clinical value of total plasma cell-free DNA in hepatitis B virus-related hepatocellular carcinoma.

Authors:  Dong Wang; Xi Hu; Guo Long; Liang Xiao; Zhi-Ming Wang; Le-Du Zhou
Journal:  Ann Transl Med       Date:  2019-11

3.  Comparison of paired cerebrospinal fluid and serum cell-free mitochondrial and nuclear DNA with copy number and fragment length.

Authors:  Aolong Chen; Jun Li; Lei Wang; Qin Huang; Jiajin Zhu; Shumeng Wen; Jianxin Lyu; Wenhe Wu
Journal:  J Clin Lab Anal       Date:  2020-02-13       Impact factor: 2.352

4.  Associations of circulating cell-free DNA, C-reactive protein, and cardiometabolic risk among low-active smokers with elevated depressive symptoms.

Authors:  Teresa E Daniels; Emily K Zitkovsky; Zachary J Kunicki; Destiny J Price; Abigail L Peterson; Phyllis A Dennery; Hung-Teh Kao; Lawrence H Price; Audrey R Tyrka; Ana M Abrantes
Journal:  Brain Behav Immun Health       Date:  2022-09-19

5.  Prognostic significance of total plasma cell-free DNA level and androgen receptor amplification in castration-resistant prostate cancer.

Authors:  Yuka Kubota; Shingo Hatakeyama; Tohru Yoneyama; Mihoko Sutoh Yoneyama; Itsuto Hamano; Sakae Konishi; Teppei Okamoto; Hayato Yamamoto; Takahiro Yoneyama; Yasuhiro Hashimoto; Chikara Ohyama
Journal:  World J Urol       Date:  2021-03-06       Impact factor: 4.226

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.